These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 28130911

  • 1. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
    El Said HW, Abou Seif KH, Ahmed YS, Abou Elleil HA, El Said TW, Behairy MA, Mohamed MM, Ahmed FA.
    Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
    [Abstract] [Full Text] [Related]

  • 2. Serum hemojuvelin and hepcidin levels in chronic kidney disease.
    Rumjon A, Sarafidis P, Brincat S, Musto R, Malyszko J, Bansal SS, Macdougall IC.
    Am J Nephrol; 2012 Apr; 35(3):295-304. PubMed ID: 22398782
    [Abstract] [Full Text] [Related]

  • 3. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S, Alkim H, Alkim C, Koksal AR, Bayram M, Yilmaz Ozguven MB, Tekin Neijmann S.
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S.
    Intern Med; 2019 Oct 15; 58(20):2915-2922. PubMed ID: 31243222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H, Kobayashi Y, Onuma S, Shibagaki K, Yuza T, Hirao K, Yamamoto T, Tomosugi N, Shibata T.
    PLoS One; 2016 Oct 15; 11(3):e0151601. PubMed ID: 26978524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin.
    Bilar JM, Fucuta PDS, Feldner AC, Caravalho Filho R, Silva I, Pestana JM, Ferraz ML.
    Transplant Proc; 2020 Oct 15; 52(1):169-174. PubMed ID: 31955851
    [Abstract] [Full Text] [Related]

  • 12. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
    Petrulienė K, Žiginskienė E, Kuzminskis V, Nedzelskienė I, Bumblytė IA.
    Medicina (Kaunas); 2017 Oct 15; 53(2):90-100. PubMed ID: 28416170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, Kaito M.
    Mol Med; 2007 Oct 15; 13(1-2):97-104. PubMed ID: 17515961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S.
    Eur J Haematol; 2013 Mar 15; 90(3):237-44. PubMed ID: 23281632
    [Abstract] [Full Text] [Related]

  • 17. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
    Touzot M, Lefebvre T, Roux A, Maheas C, Ridel C, Puy H, Karim Z.
    Nephrology (Carlton); 2019 Jul 15; 24(7):751-757. PubMed ID: 30175513
    [Abstract] [Full Text] [Related]

  • 18. Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.
    Brătescu LO, Bârsan L, Gârneaţă L, Stanciu A, Lipan M, Stancu SH, Mircescu G.
    Int Urol Nephrol; 2014 May 15; 46(5):1005-12. PubMed ID: 24800994
    [Abstract] [Full Text] [Related]

  • 19. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar 15; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 20. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
    Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB.
    Clin J Am Soc Nephrol; 2010 Jun 15; 5(6):1010-4. PubMed ID: 20299375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.